Literature DB >> 18006944

Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.

Morgan Rouprêt1, Géraldine Cancel-Tassin, Eva Comperat, Gaëlle Fromont, Mathilde Sibony, Vincent Molinié, Yves Allory, Stéphane Triau, Jacqueline Champigneulle, Cécile Gaffory, Stéphane Larré, Alexandre de la Taille, François Richard, Freddie C Hamdy, Olivier Cussenot.   

Abstract

Cytosolic sulfotransferases (SULT) are involved in detoxification pathways. A functional polymorphism in the SULT1A1 gene, leading to an Arg213His substitution (SULT1A1*2), is thought to confer susceptibility to various types of cancer. Upper urinary tract urothelial cell carcinomas (UUT-UCC) are rare (5% of all urothelial carcinomas). We genotyped 268 patients with UUT-UCC and 268 healthy controls matched for age, gender, tobacco consumption, and ethnicity. His213 (SULT1A1*2) allele frequency was significantly higher in patients than in controls (37.1% versus 28.9%; P=0.004). The His/His genotype corresponding to low-activity SULT1A1 enzyme conferred a significantly higher risk of UUT-UCC (odds ratio, 2.18; 95% confidence interval, 1.28-3.69; P=0.004

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006944     DOI: 10.1158/1055-9965.EPI-07-0361

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms.

Authors:  Morgan Rouprêt; Pierre Colin
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

Review 2.  Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.

Authors:  David R Yates; James W F Catto
Journal:  World J Urol       Date:  2012-09-18       Impact factor: 4.226

3.  Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.

Authors:  David R Yates; Morgan Rouprêt; Sarah J Drouin; Marie Audouin; Géraldine Cancel-Tassin; Eva Comperat; Marc-Olivier Bitker; Olivier Cussenot
Journal:  World J Urol       Date:  2012-09-28       Impact factor: 4.226

4.  Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.

Authors:  Kang Liu; Jiaxin Ye; Yuan Huang; Chao Qin; Pu Li; Bianjiang Liu; Jie Li; Changjun Yin
Journal:  Mol Clin Oncol       Date:  2014-09-01

Review 5.  Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.

Authors:  Ada W. Y. Leung; Ian Backstrom; Marcel B Bally
Journal:  Oncotarget       Date:  2016-08-23

6.  Bioactivation of the human carcinogen aristolochic acid.

Authors:  Viktoriya S Sidorenko; Sivaprasad Attaluri; Irina Zaitseva; Charles R Iden; Kathleen G Dickman; Francis Johnson; Arthur P Grollman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

7.  SULT1A1 genetic polymorphisms and the association between smoking and oral cancer in a case-control study in Brazil.

Authors:  Sabrina S Santos; Rosalina J Koifman; Rafaela M Ferreira; Lilian F Diniz; Paul Brennan; Paolo Boffetta; Sergio Koifman
Journal:  Front Oncol       Date:  2012-12-18       Impact factor: 6.244

8.  Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: a meta-analysis of 53 case-control studies.

Authors:  Juanjuan Xiao; Yabiao Zheng; Yinghui Zhou; Ping Zhang; Jianguo Wang; Fangyuan Shen; Lixia Fan; Vijay Kumar Kolluri; Weiping Wang; Xiaolong Yan; Minghua Wang
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.